摘要
目的对美托洛尔在风湿性心脏病治疗中的临床应用效果进行分析研究。方法选取于2012年3月~2015年5月经临床确诊并且在我院接受治疗的风湿性心脏病患者62例,将患者随机分为对照组（29例）和治疗组（33例）进行对照研究,观察常规治疗和美托洛尔治疗的效果并进行比较。结果治疗组患者的显效率和治疗总有效率分别为72.7%和90.9%,均高于对照组患者的37.9%和72.4%;同时治疗组患者的左室射血分数高于对照组,左室舒张末期内径和心功能指数均低于对照组,差异具有统计学意义（P〈0.05）。结论美托洛尔在风湿性心脏病治疗中具有临床应用效果,能够使患者的心功能以及治疗效果得到提高。
Objective Clinical application effect of metoprolol in treatment of rheumatic heart disease is to be studied.MethodsChose 62 patients of rheumatic heart disease who were treated in hospital from March 2012 to May 2015,and separated 29 patients into control group and 33 patients into study group at random, and then observed and compared clinical effects of conventional treatment and metoprolol medication treatment between two groups. ResultsPatients’treatment efficacy and total efficiency in study group were 72.7% and 90.9%,which were much higher than 37.9% and 72.4%, besides,patients’left ventricular ejection scores in study group were significantly higher than patients in control group.And patients’end-diastolic diameter of left ventricular and their cardiac function index in study group were much lower than counterparts in control group. There was a differential between two groups and such a differential had statistic value（P〈 0.05）.Conclusion Metoprolol medication is of great clinical efficacy in treatment of rheumatic heart disease. It is conducive to promoting patients’cardiac function and increasing treatment efficacy.
出处
《中国卫生标准管理》
2015年第24期92-93,共2页
China Health Standard Management
关键词
美托洛尔
风湿性心脏病
治疗
Metoprolol
Rheumatic Heart Disease
Treatment
